As part of client teaching about miotics, the nurse describes the symptoms indicative of drug toxicity
The highest priority nursing intervention when systemic toxicity is suspected after the client has been treated with a miotic medication is to administer.
a. cascara.
b. calcium gluconate.
c. demecarium bromide.
d. atropine sulfate.
ANS: D
Atropine is the antidote to the parasympathetic stimulation of the miotics.
You might also like to view...
The nurse is performing an assessment of the client's head and neck. The client requests information about the assessment of her lymph nodes. Which of the following is the best response?
1. "Sometimes, enlarged lymph nodes indicate an infection.". 2. "All of your lymph nodes should be easily palpable.". 3. "The lymph system makes antibiotics to treat infection.". 4. "When one lymph node is identified as being enlarged, this is always an abnormal finding.".
During the health interview, the older adult complains of vague physical gastrointestinal complaints, the inability to fall asleep, frequent periods of wakefulness during the night, and a decrease in appetite. What should the nurse inquire about?
a. Feelings of depression b. Time of last bowel movement c. Environmental stimuli that disturb sleep d. Frequency and size of meals
The nursing theorist Peplau identified which of the following as the essence of psychiatric–mental health nursing?
A) Nursing care independent of physicians B) The nurse's use of self C) The nurse–patient relationship D) A neurobiologic approach
A client who is terminally ill reports hearing about a drug that is in preclinical investigation. The client asks the nurse if the drug will be available to the public soon. What should the nurse consider when formulating an answer to this question?
1. After preclinical investigation the drug has one more step before being released for public use. 2. The average length of preclinical investigation is 18 months. 3. When the drug reaches the clinical investigation stage it is usually released within 2 years. 4. The drug will not be available until after the post-marketing studies are done.